Defects in the medial entorhinal cortex and dentate gyrus in the mouse model of Sanfilippo syndrome type B

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Ohmi, Kazuhiro ^a   Zhao, Hui Zhi ^a   Neufeld, Elizabeth F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; GLYCOSAMINOGLYCAN; GLYPICAN; GLYPICAN 1; GLYPICAN 5; HEPARAN SULFATE; LITHIUM CHLORIDE; PROTEOHEPARAN SULFATE; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DENTATE GYRUS; ENTORHINAL CORTEX; GENE; MALE; MOUSE; NAGLU GENE; NERVE CELL; NONHUMAN; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SANFILIPPO SYNDROME; SANFILIPPO SYNDROME TYPE B; AGE; ANIMAL; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY;

MUS;

AGE FACTORS; AMYLOID BETA-PEPTIDES; ANIMALS; DENTATE GYRUS; DISEASE MODELS, ANIMAL; ENTORHINAL CORTEX; GLYPICANS; IMMUNOHISTOCHEMISTRY; MICE; MUCOPOLYSACCHARIDOSIS III;

EID: 80655128613     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027461     Document Type: Article

References (43)

1. Neufeld EF, Muenzer J, (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. ed 3421- 3452 New York McGraw-Hill.
2. Li HH, Yu WH, Rozengurt N, Zhao HZ, Lyons KM, et al. (1999) Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc Natl Acad Sci USA 96: 14505-14510.
3. Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, et al. (2003) Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci USA 100: 1902-1907.
4. Ausseil J, Desmaris N, Bigou S, Attali R, Corbineau S, et al. (2008) Early neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB mice. PLoS ONE 3: e2296.
5. Villani GR, Gargiulo N, Faraonio R, Castaldo S, Gonzalez YRE, et al. (2007) Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB. J Neurosci Res 85: 612-622.
6. DiRosario J, Divers E, Wang C, Etter J, Charrier A, et al. (2009) Innate and adaptive immune activation in the brain of MPS IIIB mouse model. J Neurosci Res 87: 978-990.
7. Killedar S, Dirosario J, Divers E, Popovich PG, McCarty DM, et al. (2010) Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response. J Neuroinflammation 7: 39.
8. Li HH, Zhao HZ, Neufeld EF, Cai Y, Gomez-Pinilla F, (2002) Attenuated plasticity in neurons and astrocytes in the mouse model of Sanfilippo syndrome type B. J Neurosci Res 69: 30-38.
9. Heldermon CD, Hennig AK, Ohlemiller KK, Ogilvie JM, Herzog ED, et al. (2007) Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B. PLoS ONE 2: e772.
10. Canal MM, Wilkinson FL, Cooper JD, Wraith JE, Wynn R, et al. (2010) Circadian rhythm and suprachiasmatic nucleus alterations in the mouse model of mucopolysaccharidosis IIIB. Behav Brain Res 209: 212-220.
11. Cressant A, Desmaris N, Verot L, Brejot T, Froissart R, et al. (2004) Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum. J Neurosci 24: 10229-10239.
12. Malinowska M, Wilkinson FL, Langford-Smith KJ, Langford-Smith A, Brown JR, et al. (2010) Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease. PLoS ONE 5: e14192.
13. Yu WH, Zhao KW, Ryazantsev S, Rozengurt N, Neufeld EF, (2000) Short-term enzyme replacement in the murine model of Sanfilippo syndrome type B. Mol Genet Metab 71: 573-580.
14. Fu H, DiRosario J, Kang L, Muenzer J, McCarty DM, (2010) Restoration of central nervous system alpha-N-acetylglucosaminidase activity and therapeutic benefits in mucopolysaccharidosis IIIB mice by a single intracisternal recombinant adeno-associated viral type 2 vector delivery. J Gene Med 12: 624-633.
15. McCarty DM, DiRosario J, Gulaid K, Muenzer J, Fu H, (2009) Mannitol-facilitated CNS entry of rAAV2 vector significantly delayed the neurological disease progression in MPS IIIB mice. Gene Ther 16: 1340-1352.
16. Fu H, Kang L, Jennings JS, Moy SS, Perez A, et al. (2007) Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice. Gene Ther 14: 1065-1077.
17. Di Domenico C, Villani GR, Di Napoli D, Nusco E, Cali G, et al. (2009) Intracranial gene delivery of LV-NAGLU vector corrects neuropathology in murine MPS IIIB. Am J Med Genet A 149A: 1209-1218.
18. Zheng Y, Ryazantsev S, Ohmi K, Zhao HZ, Rozengurt N, et al. (2004) Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB. Mol Genet Metab 82: 286-295.
19. Fu H, Dirosario J, Killedar S, Zaraspe K, McCarty DM, (2011) Correction of Neurological Disease of Mucopolysaccharidosis IIIB in Adult Mice by rAAV9 Trans-Blood-Brain Barrier Gene Delivery. Mol Ther 19: 1025-1033.
20. Ryazantsev S, Yu WH, Zhao HZ, Neufeld EF, Ohmi K, (2007) Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III B. Mol Genet Metab 90: 393-401.
21. Elleder M, Sokolová J, Hrebícek M, (1997) Follow-up study of subunit c of mitochondrial ATP synthase (SCMAS) in Batten disease and in unrelated lysosomal disorders. Acta Neuropathol (Berl) 93: 379-390.
22. Ohmi K, Kudo LC, Ryazantsev S, Zhao HZ, Karsten SL, et al. (2009) Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy. Proc Natl Acad Sci USA 106: 8332-8337.
23. Hernandez F, Avila J, (2007) Tauopathies. Cell Mol Life Sci 64: 2219-2233.
24. Litwack ED, Ivins JK, Kumbasar A, Paine-Saunders S, Stipp CS, et al. (1998) Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent. Dev Dyn 211: 72-87.
25. David G, Bai XM, Van der Schueren B, Cassiman JJ, Van den Berghe H, (1992) Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol 119: 961-975.
26. Wang QM, Fiol CJ, DePaoli-Roach AA, Roach PJ, (1994) Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. J Biol Chem 269: 14566-14574.
27. Klein PS, Melton DA, (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93: 8455-8459.
28. Kayed R, Head E, Sarsoza F, Saing T, Cotman CW, et al. (2007) Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener 2: 18.
29. Kirkin V, McEwan DG, Novak I, Dikic I, (2009) A role for ubiquitin in selective autophagy. Mol Cell 34: 259-269.
30. Lazarus BD, Love DC, Hanover JA, (2009) O-GlcNAc cycling: implications for neurodegenerative disorders. Int J Biochem Cell Biol 41: 2134-2146.
31. Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, et al. (1996) Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 16: 4491-4500.
32. Kirkitadze MD, Bitan G, Teplow DB, (2002) Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J Neurosci Res 69: 567-577.
33. Li X, Friedman AB, Roh MS, Jope RS, (2005) Anesthesia and post-mortem interval profoundly influence the regulatory serine phosphorylation of glycogen synthase kinase-3 in mouse brain. J Neurochem 92: 701-704.
34. Muniz M, Riezman H, (2000) Intracellular transport of GPI-anchored proteins. Embo J 19: 10-15.
35. McGlynn R, Dobrenis K, Walkley SU, (2004) Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders. J Comp Neurol 480: 415-426.
36. Settembre C, Fraldi A, Jahreiss L, Spampanato C, Venturi C, et al. (2008) A block of autophagy in lysosomal storage disorders. Hum Mol Genet 17: 119-129.
37. Allen Mouse Brain Atlas (2006) Allen Institute for Brain Science.
38. Vitry S, Bruyere J, Hocquemiller M, Bigou S, Ausseil J, et al. (2010) Storage vesicles in neurons are related to Golgi complex alterations in mucopolysaccharidosis IIIB. Am J Pathol 177: 2984-2999.
39. Tumova S, Woods A, Couchman JR, (2000) Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions. Int J Biochem Cell Biol 32: 269-288.
40. Ancsin JB, (2003) Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit. Amyloid 10: 67-79.
41. Sandwall E, O'Callaghan P, Zhang X, Lindahl U, Lannfelt L, et al. (2010) Heparan sulfate mediates amyloid-beta internalization and cytotoxicity. Glycobiology 20: 533-541.
42. Arrasate M, Perez M, Valpuesta JM, Avila J, (1997) Role of glycosaminoglycans in determining the helicity of paired helical filaments. Am J Pathol 151: 1115-1122.
43. Comer FI, Vosseller K, Wells L, Accavitti MA, Hart GW, (2001) Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. Anal Biochem 293: 169-177.